Literature DB >> 16816786

Defining and diagnosing involuntary emotional expression disorder.

Jeffrey L Cummings1, David B Arciniegas, Benjamin R Brooks, Robert M Herndon, Edward C Lauterbach, Erik P Pioro, Robert G Robinson, Douglas W Scharre, Randolph B Schiffer, Daniel Weintraub.   

Abstract

Uncontrollable episodes of emotional expression occur in a variety of neurological conditions. This emotional disinhibition syndrome is characterized by episodes of crying or laughing that are unrelated to or out of proportion to the eliciting stimulus. This syndrome is common among patients with amyotrophic lateral sclerosis, multiple sclerosis, stroke, and traumatic brain injury and a variety of terms and definitions have been used to describe it. The confusing nomenclature has been a barrier to understanding, diagnosis, and treatment of this disorder. The authors propose a unifying term, involuntary emotional expression disorder (IEED), and provide diagnostic criteria for this disorder.

Entities:  

Mesh:

Year:  2006        PMID: 16816786     DOI: 10.1017/s1092852900026614

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  30 in total

1.  Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment.

Authors:  Ida S Haussleiter; Martin Brüne; Georg Juckel
Journal:  Ther Adv Neurol Disord       Date:  2009-01       Impact factor: 6.570

Review 2.  Involuntary emotional expressive disorder: a case for a deeper neuroethics.

Authors:  Peter J Whitehouse; Sara Waller
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

Review 3.  Pathological laughing and crying : epidemiology, pathophysiology and treatment.

Authors:  Hal S Wortzel; Timothy J Oster; C Alan Anderson; David B Arciniegas
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

4.  Poststroke emotional incontinence: is it depression?

Authors:  Jong S Kim
Journal:  Curr Neurol Neurosci Rep       Date:  2012-12       Impact factor: 5.081

Review 5.  Current concepts in the pharmacotherapy of pseudobulbar affect.

Authors:  Erik P Pioro
Journal:  Drugs       Date:  2011-06-18       Impact factor: 9.546

6.  Involuntary emotional expression disorder (IEED) in Parkinson's disease.

Authors:  Lisa Phuong; Shalini Garg; John E Duda; Matthew B Stern; Daniel Weintraub
Journal:  Parkinsonism Relat Disord       Date:  2009-01-31       Impact factor: 4.891

7.  The causes and treatment of pseudobulbar affect in ischemic stroke.

Authors:  Preethi Balakrishnan; Howard Rosen
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-06

Review 8.  Dextromethorphan/quinidine sulfate for pseudobulbar affect.

Authors:  Howard Rosen
Journal:  Drugs Today (Barc)       Date:  2008-09       Impact factor: 2.245

9.  The impact of vascular burden on behavioural and psychological symptoms in older adults with dementia: the BEVASDE study.

Authors:  Raquel Manso-Calderón; Purificación Cacabelos-Pérez; María D Sevillano-García; María E Herrero-Prieto; Rogelio González-Sarmiento
Journal:  Neurol Sci       Date:  2019-09-07       Impact factor: 3.307

10.  Pharmacotherapy for the Pseudobulbar Affect in Individuals Who Have Sustained a Traumatic Brain Injury: a Systematic Review.

Authors:  Amelia J Hicks; Fiona J Clay; Jennie L Ponsford; Luke A Perry; Mahesh Jayaram; Rachel Batty; Malcolm Hopwood
Journal:  Neuropsychol Rev       Date:  2020-01-15       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.